All In Biotech

Drug Trial Radar · NCT06365788

Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer

A Multicenter Single Arm Phase II Study With Bicalutamide in Combination With Abemaciclib in 4 Cohorts of Locoregionally Advanced Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer

Last checked: Nov 20, 2026Latest source record: Apr 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

53

Planned (sponsor's estimate)

Start

Apr 8, 2024

Primary completion

Dec 2027

Study completion Dec 2028

Sponsor

Lead sponsor
Universitaire Ziekenhuizen KU LeuvenAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Kom Op Tegen Kanker; Eli Lilly and Company; Teva Pharma
First posted
Apr 15, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study has as goal to evaluate the use of abemaciclib and bicalutamide in androgen receptor positive metastatic triple negative breast cancer.

Conditions

  • Triple Negative Breast Neoplasms

Interventions

  • AbemaciclibDrug

    150 mg tablet orally twice daily

  • BicalutamideDrug

    150 mg tablet orally once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with disease control at 16 weeksTime frame: Week 16

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • ZAS Augustinus

    Antwerp, Belgium · Recruiting

  • Antwerp University Hospital

    Antwerp, Belgium · Not yet recruiting

  • University Hospital Brussels

    Brussels, Belgium · Recruiting

  • Ghent University Hospital

    Ghent, Belgium · Recruiting

  • Jessa Ziekenhuis

    Hasselt, Belgium · Recruiting

  • University Hospitals Leuven

    Leuven, Belgium · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.